256 related articles for article (PubMed ID: 29231160)
1. Oxaliplatin-induced acute tubulointerstitial nephritis: Two case reports
.
Choi YJ; Oh KH; Kang HR; Lee SJ
Clin Nephrol; 2018 Feb; 89(2):130-134. PubMed ID: 29231160
[TBL] [Abstract][Full Text] [Related]
2. A case of biopsy-proven oxaliplatin-induced acute tubulointerstitial nephritis with thrombocytopenia and anemia.
Yamada S; Yazawa M; Yamamoto M; Koitabashi K; Ichikawa D; Koike J; Shibagaki Y
CEN Case Rep; 2019 Aug; 8(3):188-193. PubMed ID: 30827015
[TBL] [Abstract][Full Text] [Related]
3. Atypical presentation of fever as hypersensitivity reaction to oxaliplatin.
Khurana A; Mitsis D; Kowlgi GN; Holle LM; Clement JM
J Oncol Pharm Pract; 2016 Apr; 22(2):319-24. PubMed ID: 25361599
[TBL] [Abstract][Full Text] [Related]
4. [A case of hypersensitivity reaction to reintroduced-oxaliplatin at the second course of oxaliplatin-based chemotherapy after neoadjuvant chemotherapy for liver metastases from colon cancer].
Katayose Y; Nakagawa K; Onogawa T; Yoshida H; Motoi F; Naitoh T; Rikiyama T; Egawa S; Unno M
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2651-3. PubMed ID: 22189236
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin-induced renal tubular vacuolization.
Joybari AY; Sarbaz S; Azadeh P; Mirafsharieh SA; Rahbari A; Farasatinasab M; Mokhtari M
Ann Pharmacother; 2014 Jun; 48(6):796-800. PubMed ID: 24615628
[TBL] [Abstract][Full Text] [Related]
6. Radiation recall with oxaliplatin: report of a case and a review of the literature.
Chan RT; Au GK; Ho JW; Chu KW
Clin Oncol (R Coll Radiol); 2001; 13(1):55-7. PubMed ID: 11292139
[TBL] [Abstract][Full Text] [Related]
7. Successful desensitization to oxaliplatin.
Mis L; Fernando NH; Hurwitz HI; Morse MA
Ann Pharmacother; 2005 May; 39(5):966-9. PubMed ID: 15784807
[TBL] [Abstract][Full Text] [Related]
8. Sudden hearing loss due to oxaliplatin use in a patient with colon cancer.
Güvenç MG; Dizdar D; Dizdar SK; Okutur SK; Demir G
J Chemother; 2016 Aug; 28(4):341-2. PubMed ID: 25872564
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.
Bautista MA; Stevens WT; Chen CS; Curtis BR; Aster RH; Hsueh CT
J Hematol Oncol; 2010 Mar; 3():12. PubMed ID: 20346128
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.
Cortazar FB; Marrone KA; Troxell ML; Ralto KM; Hoenig MP; Brahmer JR; Le DT; Lipson EJ; Glezerman IG; Wolchok J; Cornell LD; Feldman P; Stokes MB; Zapata SA; Hodi FS; Ott PA; Yamashita M; Leaf DE
Kidney Int; 2016 Sep; 90(3):638-47. PubMed ID: 27282937
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.
Woo HS; Lee KH; Yoon PH; Kim SJ; Park I; Kim YS; Ahn HK; Hong J; Shin DB; Sym SJ
Cancer Res Treat; 2015 Oct; 47(4):949-53. PubMed ID: 25544580
[TBL] [Abstract][Full Text] [Related]
12. [Three cases of fatal thrombocytopenia after oxaliplatin-based chemotherapy].
Osumi H; Shinozaki E; Kumekawa Y; Ogura M; Ozaka M; Suenaga M; Matsusaka S; Chin K; Mizunuma N; Yokoyama M
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1557-60. PubMed ID: 24231715
[TBL] [Abstract][Full Text] [Related]
13. Eosinophilic tubulointerstitial nephritis on treatment with isotretinoin.
Kaya Aksoy G; Koyun M; Akkaya B; Comak E; Gemici A; Akman S
Eur J Pediatr; 2016 Dec; 175(12):2005-2006. PubMed ID: 27629781
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic diabetes insipidus and tubulointerstitial nephritis during continuous therapy with rifampin.
Quinn BP; Wall BM
Am J Kidney Dis; 1989 Sep; 14(3):217-20. PubMed ID: 2773924
[TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
Bhargava P; Gammon D; McCormick MJ
Cancer; 2004 Jan; 100(1):211-2. PubMed ID: 14692042
[No Abstract] [Full Text] [Related]
16. A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.
Yoshida Y; Hirata K; Matsuoka H; Iwamoto S; Kotaka M; Fujita H; Aisu N; Hoshino S; Kosaka T; Maeda K; Kiyomi F; Yamashita Y
Drug Des Devel Ther; 2015; 9():6067-73. PubMed ID: 26648694
[TBL] [Abstract][Full Text] [Related]
17. Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institution.
Lenz G; Hacker UT; Kern W; Schalhorn A; Hiddemann W
Anticancer Drugs; 2003 Oct; 14(9):731-3. PubMed ID: 14551506
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report.
Koda R; Watanabe H; Tsuchida M; Iino N; Suzuki K; Hasegawa G; Imai N; Narita I
BMC Nephrol; 2018 Feb; 19(1):48. PubMed ID: 29486725
[TBL] [Abstract][Full Text] [Related]
19. Tubulointerstitial nephritis and cancer chemotherapy: update on a neglected clinical entity.
Airy M; Raghavan R; Truong LD; Eknoyan G
Nephrol Dial Transplant; 2013 Oct; 28(10):2502-9. PubMed ID: 24009289
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.
Buti S; Riccò M; Chiesa MD; Copercini B; Tomasello G; Brighenti M; Passalacqua R
Anticancer Drugs; 2007 Mar; 18(3):297-300. PubMed ID: 17264762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]